Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02437890 |
|---|---|
| Brief Title: | A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus |
| First Submitted : | April 29, 2015 |
| First Submitted that Met QC Criteria : | May 7, 2015 |
| First Posted : | May 8, 2015 (Estimate) |
| Results First Submitted : | November 16, 2018 |
| Results First Submitted that Met QC Criteria : | January 17, 2019 |
| Results First Posted : | February 6, 2019 |
| Certification/Extension First Submitted : | November 5, 2018 |
| Certification/Extension First Submitted that Met QC Criteria : | November 5, 2018 |
| Certification/Extension First Posted : | November 6, 2018 |
| Last Update Submitted that Met QC Criteria : | February 12, 2019 |
| Last Update Posted : | February 26, 2019 |